MUSTANG BIO, INC. MBIO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-08-22
MUSTANG BIO, INC. statistics & valuation
Market cap$5.3M
P / B0.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -10.9% | -169.2% | -290.8% | -83.9% | -53.0% |
| Return on equity | -20.2% | 406.7% | -41952.8% | -167.5% | -59.0% |
| Current ratio | 2.22 | 0.68 | 0.74 | 5.22 | 10.33 |
Source: SEC EDGAR filings · CIK 0001680048 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.